CC
Cherington Charles
董事
BoardM
内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Cherington Charles, 董事. Director active across 4 companies, notably Brooklyn ImmunoTherapeutics, Inc.. In total, 16 filings have been logged. Breakdown: 14 buys · 1 sell. Total volume traded: €7.4m. Activity tracked since 16 June 2021. The latest transaction was filed on 10 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cherington Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
4,000,000 股@ US$0.5046.4% 占其流量Common StockSEC:0001104659-26-016680:0
21,241,163 股@ US$0.1046100.0% 占其流量Common StockSEC:0001104659-25-058644:0
261,756 股Common StockSEC:0001104659-25-045416:0
3,768,397 股@ US$0.104630.7% 占其流量Common StockSEC:0001104659-25-032060:0
261,756 股Common StockSEC:0001104659-24-114222:0
2,053,789 股@ €0.475541.8% 占其流量Common StockSEC:0001104659-23-099800:0
880,195 股@ €0.464917.5% 占其流量Common StockSEC:0001104659-23-095433:0
743,243 股@ €1.166237.1% 占其流量Common StockSEC:0000899243-23-001182:0
261,756 股@ US$3.2869.3% 占其流量Common StockSEC:0001140361-22-044639:0
3,316 股@ €1.55680.2% 占其流量Common StockSEC:0001062993-22-021051:0
4,253 股@ €1.64510.3% 占其流量Common StockSEC:0001062993-22-020905:0
10,481 股@ €1.70120.8% 占其流量Common StockSEC:0001062993-22-020800:0
17,900 股@ €1.90261.5% 占其流量Common StockSEC:0001062993-22-020096:0
12,000 股@ €1.7560.9% 占其流量Common StockSEC:0001062993-22-020051:0
92 股0Common StockSEC:0001140361-21-041286:0
200,000 股@ US$15.7338100.0% 占其流量Common StockSEC:0001140361-21-021772:0
About Cherington Charles
Cherington Charles is Administrateur of Comera Life Sciences Holdings, Inc., Ernexa Therapeutics Inc., and Eterna Therapeutics Inc., and Director at Brooklyn ImmunoTherapeutics, Inc. He has 16 filings in total, and in the recent filings sampled from 2021-06-21 to 2026-02-17, purchases amount to EUR 4801095 and sales to EUR 2623265, with Acquisition as the most frequent transaction nature.